Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults.

The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus... Prevalence of human papillomavirus (HPV)-associated oral condylomas has reportedly increased in HIV-infected individuals since the introduction of highly active antiretroviral therapy (HAART). The relationships between HIV therapy regimen, overall health, and subclinical oral HPV have not been examined. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Sexually transmitted diseases Pubmed

The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults.

Sexually transmitted diseases , Volume 32 (11): -693 – Jan 3, 2006

The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults.


Abstract

Prevalence of human papillomavirus (HPV)-associated oral condylomas has reportedly increased in HIV-infected individuals since the introduction of highly active antiretroviral therapy (HAART). The relationships between HIV therapy regimen, overall health, and subclinical oral HPV have not been examined.

Loading next page...
 
/lp/pubmed/the-impact-of-highly-active-antiretroviral-therapy-and-W2FCo0Cdl1

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0148-5717
DOI
10.1097/01.olq.0000175398.34610.2e
pmid
16254546

Abstract

Prevalence of human papillomavirus (HPV)-associated oral condylomas has reportedly increased in HIV-infected individuals since the introduction of highly active antiretroviral therapy (HAART). The relationships between HIV therapy regimen, overall health, and subclinical oral HPV have not been examined.

Journal

Sexually transmitted diseasesPubmed

Published: Jan 3, 2006

There are no references for this article.